Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

Market Cap	6.57B -7.9%
Revenue (ttm)	2.02B -7.1%
Net Income	463.31M -12.5%
EPS	1.97 -12.8%
Shares Out	234.33M
PE Ratio	14.23
Forward PE	10.95
Dividend	2.50 (8.92%)
Ex-Dividend Date	Oct 17, 2025

Volume	926,100
Average Volume	4,047,136
Open	28.36
Previous Close	28.04
Day's Range	27.72 - 28.36
52-Week Range	27.30 - 36.70
Beta	-0.00
RSI	34.17
Earnings Date	Apr 24, 2026

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co., Ltd. engages in the research, development, and production of children healthcare and medicine products. Its products include vitamin A and D drops, compound calcium carbonate effervescent granules, licorice zinc granules, iron dextran granules, pediatric ibuprofen suppositories, azithromycin granules, dimercaptosuccinic acid capsules, rifaximin dry suspension, and oral rehydration salt powder. The company was founded on June 26, 1993 and is headquartered in Jinan, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 1,719
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000915

Financial Performance

In 2025, Shandong Wit Dyne Health's revenue was 2.23 billion, an increase of 4.40% compared to the previous year's 2.13 billion. Earnings were 535.08 million, an increase of 3.78%.